Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multinational, Observational, Cohort Study Sepsis in Hospitalised Neonates in Areas With High Endemic Levels of Antimicrobial Resistance.

NCT03721302 is registered in ClinicalTrials.gov with Drugs for Neglected Diseases as lead sponsor.

NCT NCT03721302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03721302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multinational, Observational, Cohort Study Sepsis in Hospitalised Neonates in Areas With High Endemic Levels of Antimicrobial Resistance.
Lead sponsor
Drugs for Neglected Diseases
Phase
Observational
Overall status
Completed
Start date
August 16, 2018
Completion date
February 29, 2020
Enrollment
3,202 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

neonatal sepsis